Advertising
Agriculture
Airlines-Aviation
Aerospace-Defense
Art
Auto
Banking-Financial Services
Beer, Wine & Spirits
Biometrics
Biotechnology
Books
Charity
Chemical
Computer Electronics
Computer Gaming
Computer Hardware
Computer Networks
Computer Software
Construction-Building
Consumer Electronics
Death Care Services
Education
Electronic Commerce
Electronic Components
Electronic Design Automation
Electronics Performance Measurement
Entertainment
Environmental Services
Fashion
Film-Motion-Picture
Food-Beverages
Gambling-Casinos
Government
Health Care-Hospitals
High-Tech Security
Higher Education
Homeland Security
Household-Consumer-Cosmetics
Infectious Disease Control
Insurance
Internet Technology
Legal
Leisure-Travel-Hotels
Machinery
Magazines
Maritime-Shipbuilding
Medical-Pharmaceuticals
Mining-Metals
Mobile Entertainment
Multimedia-Online-Internet
Music
Mutual Funds
Nanotechnology
Office Products
Oil-Energy
Otc-Smallcap
Paper-Forest-Products-Containers
Peripherals
Publishing-Information Services
Radio
Real Estate
Religion
Restaurants
Retail
Safety
Semiconductors
Sports
Supermarkets
Supplementary Medicine
Telecommunications
Television
Temporary Staffing Services
Textiles
Tobacco
Transportation-Trucking-Railroad
Travel
Utilities
Workforce Management/Human Resources
News Releases For June 1, 2009

HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A (H1N1)

Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients

New Data Support Use of Simple Test to Predict Endometrial Cancer Response to Chemotherapy

FDA Approves Labeling Change for VYVANSE(R) (lisdexamfetamine dimesylate) CII to Include Supplementary Clinical Data Supporting Efficacy at 13 Hours Postdose in Children Aged 6 to 12 with ADHD

Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting

Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study

Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 ASCO Annual Meeting

IMPACT Study Showed Longer Valcyte(R) (valganciclovir hydrochloride tablets) Treatment Demonstrated Better Protection Against Cytomegalovirus (CMV) Disease One Year Post-Transplant

Findings in Epilepsy Gene in Animals May Guide Treatment Directions for Infants

Ironwood and Forest Present Additional Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2009 PR Newswire Association LLC. All Rights Reserved.
A United Business Media company.